Trends in medication use and clinical outcomes in twelve countries: Results form the dialysis outcomes and practice patterns study (DOPPS)

Contributions to Nephrology

Volumn 161, Issue , 2008, Pages 48-54

  Tentori, F ^a  

^a ARBOR RESEARCH COLLABORATIVE FOR HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; CLINICAL PRACTICE; HUMAN; LONGEVITY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME;

ADULT; ANTIHYPERTENSIVE AGENTS; ASPIRIN; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LONGEVITY; PHYSICIAN'S PRACTICE PATTERNS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 48049098455     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000129753     Document Type: Conference Paper

References (12)

1. Young EW, Goodkin DA, Mapes DL, et al: The Dialysis Outomes and Practice Patterns Study (DOPPS): an international hemodialysis study. Kidney Int 2000;57:S74-S81.
2. Pisoni RL, Gillespie BW, Dickinson DM, et al: The Dialysis Outcomes and Practice Patterns Study (DOPPS): design, data elements, and methodology. Am J Kidney Dis 2004;44:7-15.
3. Port FK, Wolfe RA, Held PJ, et al: Random sample (DOPPS) versus census-based (registry) approaches to kidney disease research. Blood Purif 2003;21:85-88.
4. Bragg-Gresham JL, Fissell RB, Mason NA, et al: Diuretic use, residual renal function, and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS). Am J Kidney Dis 2007;49:426-431.
5. Saran R, Dykstra DM, Wolfe RA, et al: Association between vascular access failure and the use of specific drugs: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2002;40:1255-1263.
6. Bailie GR, Elder SJ, Mason NA, et al: Sexual dysfunction in dialysis patients treated with antihypertensive or antidepressive medications: results from the DOPPS. Nephrol Dial Transplant 2007;22:1163-1170.
7. Mason NA, Bailie GR, Satayathum S, et al: HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients. Am J Kidney Dis 2005;45:119-126.
8. Ethier J, Bragg-Gresham JL, Piera L, et al: Aspirin prescription and outcomes in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2007;50:602-611.
9. Bailie GR, Mason NA, Elder SJ, et al: Large variations in prescriptions of gastrointestinal medications in hemodialysis patients on three continents: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Hemodial Int 2006;10:180-188.
10. Bailie GR, Mason NA, Bragg-Gresham JL, et al: Analgesic prescription patterns among hemodialysis patients in the DOPPS: potential for underprescription. Kidney Int 2004;65:2419-2425.
11. Fissell RB, Bragg-Gresham JL, Gillespie BW, et al: International variation in vitamin prescription and association with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004;44:293-299.
12. Johnston SC: Combining ecological and individual variables to reduce confounding by indication: case study-subarachnoid hemorrhage treatment. J Clin Epidemiol 2000;53:1236-1241.